Dr. Babak Baban, an immunologist at the Dental College of Georiga, found that CBD working with apelin can reduce inflammation and normalize lung function levels.[1]Baban has been principal investigator or co-investigator on 21 grants exceeding $20 million in funding since 2010.[2]The World Health Organization has cited Dr. Baban’s research study relative to CBD’s positive impact for ARDS symptoms, as happens in the last stages of severe COVID-19 infection.[3]To explore the effectiveness of CBD in reducing hyperactivated inflammatory reactions, Baban and colleagues examined the potential of CBD to ameliorate ARDS in a murine model.[4]Medicinal Cannabis of America was co-founded by world renowned immunologist Dr. Baban. Nationally, Baban has served on the National Dental Board Examination Committee, on American Heart Association Study Sections and as a Council on Dental Accreditation Site Visitor.[5]Baban is a member of several professional associations including the American Association for Cancer Research, American Dental Association, American Heart Association, American and International Associations for Dental Research, and the International Cannabinoid Research Society.[6]Baban earned his doctorate in Microbiology/Bacteriology from the University of London in the U.K., completed a postdoctoral fellowship in Molecular Immunology with the Medical College of Georgia and earned both an MBA and a MPH from AU.[7]